Profound Medical (NASDAQ: PROF)
Profound Medical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Profound Medical Company Info
Profound Medical Corp. engages in developing, manufacturing, and marketing of therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care, which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, Canada.
News & Analysis
No articles found.
Valuation
Earnings Transcripts
Profound Medical Corp. (PROF) Q2 2022 Earnings Call Transcript
PROF earnings call for the period ending June 30, 2022.
Profound Medical Corp. (PROF) Q1 2022 Earnings Call Transcript
PROF earnings call for the period ending March 31, 2022.
Profound Medical Corp. (PROF) Q4 2021 Earnings Call Transcript
PROF earnings call for the period ending December 31, 2021.
PATRIOT MINEFINDERS (PROF) Q3 2021 Earnings Call Transcript
PROF earnings call for the period ending September 30, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.